Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: A case study with artemether-lumefantrine and the CYP3A4-inducer rifampicin-Reference-Cited by-同舟云学术

Development of a paediatric physiologically based pharmacokinetic model to assess the impact of drug-drug interactions in tuberculosis co-infected malaria subjects: A case study with artemether-lumefantrine and the CYP3A4-inducer rifampicin

Published:2017-08 Issue: Volume:106 Page:20-33
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Olafuyi Olusola,Coleman Michael,Badhan Raj K.S.^ORCID

Funder

Aston University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference83 articles.

1. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria;Ashley;Tropical Med. Int. Health,2007

2. Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins;Avery;J. Med. Chem.,1995

4. Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants;Bindschedler;Am.J.Trop. Med. Hyg.,2002

5. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria;Borrmann;Tropical Med. Int. Health,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK Modeling of Entrectinib and Its Active Metabolite to Derive Dose Adjustments in Pediatric Populations Co‐Administered with CYP3A4 Inhibitors;Clinical Pharmacology & Therapeutics;2024-07-18

2. Defining the next generation of severe malaria treatment: a target product profile;Malaria Journal;2024-06-05

3. Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications;Metabolites;2023-07-29

4. Estimation of Pediatric Dosage of Antimalarial Drugs, Using Pharmacokinetic and Physiological Approach;Pharmaceutics;2023-03-27

5. The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children;International Journal for Parasitology: Drugs and Drug Resistance;2022-08